Worldwide Neurorehabilitation Industry to 2030 - Rising Demand of Telerehabilitation Presents Opportunities
February 17, 2022 05:43 ET
|
Research and Markets
Dublin, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The "Neurorehabilitation Market by Type, Application, and End-User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...
Herantis Pharma Oyj:n suunnattu osakeanti on ylimerkitty moninkertaisesti ja toteutetaan suunnitellusti
December 02, 2019 13:00 ET
|
Herantis Pharma Oyj
Herantis Pharma Oyj:n suunnattu osakeanti on ylimerkitty moninkertaisesti ja toteutetaan suunnitellusti Herantis Pharma Oyj Yhtiötiedote 2.12.2019 kello 20:00 TÄMÄN TIEDOTTEEN SISÄLTÄMÄ TIETO EI...
Herantis Pharma Plc's directed share issue is oversubscribed multiple times and completed as planned
December 02, 2019 13:00 ET
|
Herantis Pharma Oyj
Herantis Pharma Plc's directed share issue is oversubscribed multiple times and completed as planned Herantis Pharma Plc Company release 2 December 2019 at 8:00 pm THE INFORMATION CONTAINED IN...
Herantis Pharma Oyj päivittää käynnissä olevan Vaiheen 1-2 CDNF-tutkimuksen aikataulua
September 26, 2019 02:00 ET
|
Herantis Pharma Oyj
Herantis Pharma Oyj päivittää käynnissä olevan Vaiheen 1-2 CDNF-tutkimuksen aikataulua Herantis Pharma Oyj Yhtiötiedote 26.9.2019 kello 9:00 Herantis Pharma Oyj (“Herantis” tai “Yhtiö”) tiedotti...
Herantis Pharma Plc Provides Update on Timeline for Ongoing Phase 1-2 CDNF Trial
September 26, 2019 02:00 ET
|
Herantis Pharma Oyj
Herantis Pharma Plc Provides Update on Timeline for Ongoing Phase 1-2 CDNF Trial Herantis Pharma Plc Company release 26 September 2019 at 9:00 AM Herantis Pharma Plc (“Herantis” or “Company”)...
Herantis Pharma Oyj tiedottaa onnistuneesta noin 5,8 miljoonan euron suunnatusta osakeannista
March 12, 2019 11:00 ET
|
Herantis Pharma Oyj
Herantis Pharma Oyj tiedottaa onnistuneesta noin 5,8 miljoonan euron suunnatusta osakeannista Herantis Pharma Oyj Yhtiötiedote 12.3.2019 kello 17:00 Ei julkistettavaksi tai levitettäväksi, suoraan...
Herantis Pharma Plc Announces Positive Outcome of Directed Share Issue Raising EUR 5.8 Million
March 12, 2019 11:00 ET
|
Herantis Pharma Oyj
Herantis Pharma Plc Announces Positive Outcome of Directed Share Issue Raising EUR 5.8 Million Herantis Pharma Plc Company release 12 March 2019, 5:00 pm Not for publication or distribution,...
Neuronascent Announces Third US Patent Issued Covering Therapeutics for Neurodegenerative and Neuropsychiatric Disorders
January 24, 2017 06:00 ET
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - January 24, 2017) - Neuronascent's U.S. Patent No. 9,539,261, which issued on January 10, 2017, claims methods of stimulating neurogenesis and/or inhibiting neuronal...
Amarantus Biosciences, a Promising Biotech Company in Development
November 14, 2011 11:05 ET
|
Amarantus BioSciences
MIAMI, Nov. 14, 2011 (GLOBE NEWSWIRE) -- Founded in California in 2008, Amarantus Biosciences, Inc. (OTCBB:AMBS) is now poised to take the biotech world by storm with their proprietary new technology....